NFKB1 and non-small cell lung carcinoma: These findings highlight the potential for targeting the PI3K/AKT and NF-κB pathways to overcome hypoxia-induced radioresistance in NSCLC and suggest C-ion therapy as a promising alternative due to its reduced dependency on oxygenation status for efficacy.